(IBTG) iShares iBonds Dec 2026 - Ratings and Ratios
Treasury Bonds, 2026 Maturity, Government Debt, Fixed Income
| Risk via 10d forecast | |
|---|---|
| Volatility | 0.92% |
| Value at Risk 5%th | 1.36% |
| Relative Tail Risk | -10.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | 0.68 |
| Character TTM | |
|---|---|
| Hurst Exponent | |
| Beta | -0.012 |
| Beta Downside | -0.020 |
| Drawdowns 3y | |
|---|---|
| Max DD | 2.85% |
| Mean DD | 0.60% |
| Median DD | 0.24% |
Description: IBTG iShares iBonds Dec 2026 November 11, 2025
The iShares iBonds Dec 2026 Term Treasury ETF (IBTG) seeks to track an index of U.S. Treasury securities that all mature in 2026. To achieve this, the fund must allocate at least 80% of its assets to the index’s component securities and at least 90% to Treasury bonds that BlackRock’s Fixed Income team believes will best replicate the index’s performance. Because the holdings are concentrated in a single maturity bucket, the ETF is classified as non-diversified.
Key metrics to watch: the fund’s weighted average maturity is roughly 3.5 years, giving it a moderate duration exposure that will react to changes in the 2-year and 5-year Treasury yields. As of the latest data, the effective yield to maturity is around 4.2%, reflecting the market’s pricing of near-term inflation expectations and the Fed’s policy stance. The ETF’s performance is highly sensitive to the Federal Reserve’s interest-rate trajectory; a 25 bp shift in the policy rate typically moves the fund’s price by about 0.6-0.8 %.
If you want a deeper, data-driven view of how IBTG’s risk-return profile stacks up against other short-term fixed-income options, ValueRay’s analytics platform provides granular scenario modeling that can help you quantify potential outcomes.
IBTG ETF Overview
| Market Cap in USD | 2,123m |
| Category | Target Maturity |
| TER | 0.07% |
| IPO / Inception | 2020-02-25 |
| Return 12m vs S&P 500 | -8.67% |
| Analyst Rating | - |
IBTG Dividends
| Dividend Yield | 4.05% |
| Yield on Cost 5y | 4.08% |
| Yield CAGR 5y | 60.54% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
IBTG Growth Ratios
| CAGR 3y | 4.28% |
| CAGR/Max DD Calmar Ratio | 1.50 |
| CAGR/Mean DD Pain Ratio | 7.14 |
| Current Volume | 512.9k |
| Average Volume | 390.1k |
What is the price of IBTG shares?
Over the past week, the price has changed by +0.00%, over one month by +0.27%, over three months by +1.08% and over the past year by +4.69%.
Is iShares iBonds Dec 2026 a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTG is around 22.60 USD . This means that IBTG is currently overvalued and has a potential downside of -1.31%.
Is IBTG a buy, sell or hold?
What are the forecasts/targets for the IBTG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 24.6 | 7.5% |
IBTG Fundamental Data Overview November 04, 2025
Beta = 0.36
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.12b USD (2.12b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.12b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.12b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.97% (E(2.12b)/V(2.12b) * Re(5.97%) + (debt-free company))
Discount Rate = 5.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBTG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle